New USP Chapter on Method Transfer effective
![Stability Studies to Support Shipping/Distribution of Pharmaceuticals and Biopharmaceuticals - Live Online Training](files/eca/userImages/training.img/Z-ECA-Stability-Studies-Shipping-Distribution-LOT.jpg)
Recommendation
12/13 September 2024
In the Pharmacopeoial Forum (PF) from September/October 2009, a proposal for a General Chapter on method transfer was mentioned for the first time. Some time ago, a draft for a General Chapter <1224> was published in the PF. This chapter entitled "Transfer of Analytical Methods has now come into effet in the USP 35.
The method transfer is a documented process which establishes the evidence that a laboratory is qualified to use an analytical method which has been elaborated in another laboratory. Hereby the evidence must be brought that the laboratory has the knowledge and the ability to perform the analytical method as intended. The USP Chapter describes:
- the different types of transfers
- the required comparison tests
- Co-validation between two or more laboratories
- Re-validation as an alternatiive approach
- "Transfer Waiver" including justification where no method transfer is required
- Elements required for a successful method transfer
- The pre-approved transfer protocol
- The analytical method
- The transfer report
All these indications can be found in the General Chapter <1224> of USP 35.
Learn more about the new Chapter during the ECA Conference "Compliance Update: EP, USP, and JP - Update on New Monographs - Dealing with Divergent Compendial Methods", taking place from 21 - 22 June 2012 at the Corinthia Hotel in Prag, Czech Republic. Dr Chris Burgess, Member of the respective USP expert group who has elaborated the new chapter will present it.
Author:
Dr Günter Brendelberger
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)
Related GMP News
24.07.2024FDA Warning Letter to Chinese OTC Manufacturer for Lack of Analytical Test Data
10.07.2024Pharmeuropa: Two Revised Chapters on Dissolution Testing published for comments
03.07.2024FDA Warning Letter: GMP Requirements also apply to HPLC Analyses for Internal Use
12.06.2024NMPA Announcement on Application of ICH Q2(R2) and Q14 Principles
22.05.2024Q&As from the Live Online Training "Introduction to the AQCG's new AIQSV Guide" - Part 1
22.05.2024FDA Warning Letter to Contract Testing Laboratory in Uruguay due to Data Integrity Violations